Aim: The status of thrombophilia in Asian women with recurrent pregnancy loss (RPL) is obscure and poorly understood. Numerous studies suggest the non-existence or extreme rarity of the two important thrombophilia markers, factor V Leiden (FVL) and prothrombin G20210A (PTG) mutations, in patients of Asian ancestries. Thus, the consensus that thrombophilia is rare among Asians and laboratory investigations is irrelevant. We therefore investigated Malaysian women with RPL for thrombophilia abnormalities. Methods: A total of 402 patients (RPL subjects) and 160 female controls were screened for FVL, PTG and methylene tetrahydrofolate reductase mutations using polymerase chain reaction, activated protein C resistance (APC-R) using clot-based tes...
Objective: In the present study, we have aimed to determine the frequency of common inherited thromb...
Aim: The aim of the present study was to determine the existence or prevalence of thrombophilic mark...
PROBLEM: We investigated the beta2-glycoprotein I and anti-annexin V antibodies as anti-phosphol...
Recent evidences associate thrombophilia with adverse pregnancy outcome. Numerous studies confirm Fa...
Background: Recurrent pregnancy loss (RPL) caused by various genetic and non-genetic factors. After ...
Background: Recurrent pregnancy loss (RPL) caused by various genetic and non-genetic factors. After ...
Objectives: To study the prevalence and association of factor V Leiden (FVL) mutation and acquired A...
Background: The pathophysiology of recurrent pregnancy loss is poorly understood and some factors ha...
Aim: Genetic thrombophilias are known to contribute to adverse pregnancy outcomes. Studies in Wester...
Objective: In the present study, we aimed to determine the frequency of common inherited thrombophil...
Recurrent fetal loss is a frequent health problem. Data accumulated over the past few years have sug...
Recurrent fetal loss is a frequent health problem. Data accumulated over the past few years have sug...
Recurrent miscarriage (RM) affects 1% of the population. Some cases have a thrombotic aetiology. Whi...
Background: Maternal thrombophilia has been identified as a risk factor for recurrent pregnancy loss...
OBJECTIVE: To compare the prevalence of factor V Leiden (FVL) and prothrombin (PT) G20210A mutations...
Objective: In the present study, we have aimed to determine the frequency of common inherited thromb...
Aim: The aim of the present study was to determine the existence or prevalence of thrombophilic mark...
PROBLEM: We investigated the beta2-glycoprotein I and anti-annexin V antibodies as anti-phosphol...
Recent evidences associate thrombophilia with adverse pregnancy outcome. Numerous studies confirm Fa...
Background: Recurrent pregnancy loss (RPL) caused by various genetic and non-genetic factors. After ...
Background: Recurrent pregnancy loss (RPL) caused by various genetic and non-genetic factors. After ...
Objectives: To study the prevalence and association of factor V Leiden (FVL) mutation and acquired A...
Background: The pathophysiology of recurrent pregnancy loss is poorly understood and some factors ha...
Aim: Genetic thrombophilias are known to contribute to adverse pregnancy outcomes. Studies in Wester...
Objective: In the present study, we aimed to determine the frequency of common inherited thrombophil...
Recurrent fetal loss is a frequent health problem. Data accumulated over the past few years have sug...
Recurrent fetal loss is a frequent health problem. Data accumulated over the past few years have sug...
Recurrent miscarriage (RM) affects 1% of the population. Some cases have a thrombotic aetiology. Whi...
Background: Maternal thrombophilia has been identified as a risk factor for recurrent pregnancy loss...
OBJECTIVE: To compare the prevalence of factor V Leiden (FVL) and prothrombin (PT) G20210A mutations...
Objective: In the present study, we have aimed to determine the frequency of common inherited thromb...
Aim: The aim of the present study was to determine the existence or prevalence of thrombophilic mark...
PROBLEM: We investigated the beta2-glycoprotein I and anti-annexin V antibodies as anti-phosphol...